The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2017 14:25

RNS Number : 4485F
Maven Income & Growth VCT 4 PLC
17 May 2017
 

 

Maven Income and Growth VCT 4 PLC

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.30 am at Fifth Floor, 1-2 Royal Exchange Buildings, London, EC3V 3LF on 17 May 2017, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 15 May 2017, the total number of voting rights in the Company stood at 32,767,502 Ordinary Shares. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 3,972,861 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements.

3,854,111

104,885

0

13,865

3,972,861

2

To approve the Directors' Remuneration Report.

2,873,170

97,294

959,122

43,275

3,972,861

3

To approve the Directors' Remuneration Policy.

3,331,703

108,526

487,511

45,121

3,972,861

4

To approve a final dividend.

3,863,639

104,762

4,460

0

3,972,861

5

To re-elect Mr Cormack as a Director.

3,658,262

116,948

167,229

30,422

3,972,861

6

To re-elect Mr Graham-Wood as a Director.

3,654,209

122,020

166,210

30,422

3,972,861

7

To re-elect Mr Scott as a Director.

3,734,401

132,901

75,137

30,422

3,972,861

8

To re-elect Mr Nixon as a Director.

3,718,182

151,281

77,744

25,654

3,972,861

9

To re-appoint Deloitte LLP as Auditor.

3,420,186

160,474

380,571

11,630

3,972,861

10

To authorise the Directors to fix the remuneration of the Auditor.

3,794,009

141,724

17,998

19,130

3,972,861

11

To authorise the Directors to allot new shares.

3,787,895

131,600

22,735

30,631

3,972,861

12

To authorise disapplication of pre-emption rights.

3,627,875

131,600

125,146

88,240

3,972,861

13

To authorise the Company to purchase its own shares.

2,985,482

124,556

846,392

16,431

3,972,861

14

To allow a General Meeting to be called on not less than 14 days' notice.

3,446,170

387,084

117,313

22,294

3,972,861

 

The Board notes that Resolution 2, an Ordinary Resolution relating to the approval of the Directors' Remuneration Report, was duly passed but recognises that a significant minority of Shareholders have voted against the Resolution. It is intended that the Remuneration Committee will give this due consideration in its future deliberations

 

The Directors also note that Resolution 13, a Special Resolution relating to the buying back of shares, was duly passed, but once again recognise that a significant minority of Shareholders have voted against the Resolution. It is intended that the Board will consider the views expressed by Shareholders when it next seeks such an authority.

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. These proxy voting figures will also be available to view at: www.mavencp.com/migvct4.

 

 

 

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

17 May 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGBXGDUXDBBGRR
Date   Source Headline
17th Nov 20175:09 pmRNSStatement re NAV and Dividend Investment Scheme
9th Nov 20173:58 pmRNSNet Asset Value(s)
8th Nov 201710:10 amRNSResult of General Meeting
25th Oct 20173:00 pmRNSDividend Declaration
18th Oct 201710:43 amRNSReplacement Statement re Listing Application
17th Oct 20172:49 pmRNSStatement re Listing Application
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:48 pmRNSIssue of Equity
15th Sep 201710:08 amRNSStatement re NAV and Dividend Investment Scheme
8th Sep 20177:00 amRNSHalf-year Report
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
29th Aug 20174:11 pmRNSNet Asset Value(s)
10th Aug 20174:38 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
15th Jun 20174:00 pmRNSDividend Declaration
12th Jun 20174:24 pmRNSTransaction in Own Shares
17th May 20172:33 pmRNSNet Asset Value and Final Dividend
17th May 20172:25 pmRNSResult of AGM
7th Apr 20173:45 pmRNSAnnual Financial Report
2nd Mar 20173:11 pmRNSTransaction in Own Shares
28th Feb 20172:40 pmRNSNet Asset Value and Final Dividend
20th Dec 20164:51 pmRNSTransaction in Own Shares
10th Nov 201611:05 amRNSNet Asset Value(s)
23rd Sep 20165:10 pmRNSTransaction in Own Shares
20th Sep 20164:56 pmRNSTransaction in Own Shares
26th Aug 20164:07 pmRNSHalf-year Report
17th Aug 20162:12 pmRNSNet Asset Value(s)
24th May 20163:06 pmRNSTransaction in Own Shares
27th Apr 20161:50 pmRNSNet Asset Value(s) - Replacement
27th Apr 201612:58 pmRNSResult of AGM
27th Apr 201612:55 pmRNSNet Asset Value(s)
30th Mar 20165:29 pmRNSAnnual Financial Report
22nd Mar 20162:44 pmRNSTransaction in Own Shares
10th Mar 20164:55 pmRNSTransaction in Own Shares
8th Mar 20164:37 pmRNSTransaction in Own Shares
7th Mar 20164:33 pmRNSTransaction in Own Shares
2nd Mar 20164:09 pmRNSNet Asset Value and Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Nov 20154:36 pmRNSTransaction in Own Shares
17th Nov 201512:59 pmRNSTransaction in Own Shares
16th Nov 20152:17 pmRNSTransaction in Own Shares
12th Nov 201510:34 amRNSNet Asset Value(s)
4th Sep 20153:20 pmRNSTransaction in Own Shares
28th Aug 201512:20 pmRNSHalf Yearly Report
24th Aug 20153:39 pmRNSStatement re Dividend Investment Scheme
20th Aug 20154:50 pmRNSTransaction in Own Shares
20th Aug 201511:47 amRNSStatement re Net Asset Value and Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.